CSL BEHRING LLC
Lobbying client. Federal LDA filings.
- Source id
60813- General description
- Biotherapeutics company providing recombinant, plasma-derived and cell and gene products.
- State
- PA
- Country
- US
- Principal place of business
- US
- Effective date
- 2024-06-01
- Total spend (across 1 ingested filings)
- $40,000
Filings (1) — $40,000
| Posted | Type | Year | Lobbying firm | Income |
|---|---|---|---|---|
| 2026-04-20 | Q1 | 2026 | SPLITOAK STRATEGIES LLC | $40,000 |
Connected on the graph
8 typed relationships in the influence graph — 8 inbound, 0 outbound, grouped by type.
lobbied for (8)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| — | ← | Molly Fromm | — | lda_lobbyist_client | |
| — | ← | Colleen Maloney | — | lda_lobbyist_client | |
| — | ← | Sarah Kuehl Egge | — | lda_lobbyist_client | |
| — | ← | Greg D'Angelo | — | lda_lobbyist_client | |
| — | ← | Rachel Jones Hensler | — | lda_lobbyist_client | |
| — | ← | Mary Beth Savary Taylor | — | lda_lobbyist_client | |
| — | ← | Mary Lacey Reuther | — | lda_lobbyist_client | |
| — | ← | Brett Baker | — | lda_lobbyist_client |